A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...
Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...
The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...
While the statistics remain stark—lung cancer is the most common type of cancer worldwide and has the highest death ...
Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with propranolol or primidone.
AirNexis Therapeutics is a clinical-stage biotech company developing novel therapeutic drugs for the treatment of COPD patients. AN01 is a dual PDE3/4 inhibitor that exerts synergistic effects through ...
If it weren’t for the Interventional Pulmonology team at Geisinger Medical Center and the endobronchial valve procedure, Terry Loss from New Columbia would have lost his life. Believing his days were ...
Are you finding that your chronic obstructive pulmonary disease (COPD) is making it harder to do the things you enjoy? Canceling plans more often? Missing work due to flare-ups? It could mean your ...
Please provide your email address to receive an email when new articles are posted on . Smoking abstinence during week 9 to week 12 among adults with COPD was 19.1% with 12-cytisinicline vs. 4.3% with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results